Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1987 Mar;55(3):604-8.
doi: 10.1128/iai.55.3.604-608.1987.

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

Y Charoenvit, M F Leef, L F Yuan, M Sedegah, R L Beaudoin
Comparative Study

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

Y Charoenvit et al. Infect Immun. 1987 Mar.

Abstract

A battery of monoclonal antibodies against Plasmodium yoelii sporozoites was produced. Five of these (NYS1 through NYS5) were selected for characterization. All five were positive in the indirect immunofluorescent antibody test with P. yoelii sporozoites; however, each showed a different immunofluorescence pattern. Although NYS1 (immunoglobulin G3 [IgG3]), NYS2 (IgG3), and NYS3 (IgM) were positive in the circumsporozoite precipitation test, only NYS1 and NYS2 were able to neutralize sporozoite infectivity in mice. NYS4 (IgM) and NYS5 (IgG1) were not positive in the precipitation test and did not protect mice from sporozoite infection. All except NYS4 were species as well as stage specific. NYS4 cross-reacted with sporozoites of P. berghei. Electrophoretic immunoblotting analysis showed that these monoclonal antibodies detected sporozoite antigens of various molecular weights. Inhibition enzyme-linked immunosorbent assays indicated that each recognized a different antigenic epitope. The differences in their immunochemical and biological reactivity make them useful for screening a variety of P. yoelii antigens in recombinant DNA libraries. These antigens will be used in an animal model system for vaccine development.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mil Med. 1969 Sep;134(10):1183-90 - PubMed
    1. Prog Allergy. 1958;5:1-78 - PubMed
    1. J Histochem Cytochem. 1974 Dec;22(12):1084-91 - PubMed
    1. Biosystems. 1975 Mar;6(3):176-87 - PubMed
    1. J Immunol. 1979 Oct;123(4):1548-50 - PubMed

Publication types

LinkOut - more resources